Alerts will be sent to your verified email
Verify Email
GUFICBIO
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gufic Biosciences Limited, a public company from India, specializes in manufacturing and marketing active pharmaceutical ingredients and generic pharmaceuticals.
Gufic Biosciences major competitors are Zota Health Care, Orchid Pharma, Unichem Lab, Guj. Themis Biosyn, Sequent Scientific, Panacea Biotec, Indoco Remedies.
Market Cap of Gufic Biosciences is ₹3,640 Crs.
While the median market cap of its peers are ₹3,663 Crs.
Gufic Biosciences seems to be less financially stable compared to its competitors.
Altman Z score of Gufic Biosciences is 5.94 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jun Sep Dec | |||||||||||||||||
| Investor Presentation | May Aug | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Aug Sep | Mar Jun Dec | Mar Sep | ||||||||||||
| Conference Call | Mar | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
